Agendia Inc.

Agendia Inc.

Agendia is a leading provider of innovative precision oncology solutions for early-stage breast cancer. Using advanced genomic assays like MammaPrint® and BluePrint®, they enable clinicians to quickly identify the most effective treatment plan, minimizing risks of over- and undertreatment. Their FLEX Study, the world’s largest Real-World Evidence-based Breast Cancer database, aims to revolutionize precision in breast cancer management. With
cutting-edge technology and a commitment to innovation, Agendia strives to shape the future of precision oncology and combat breast cancer effectively

Breast Cancer, Medical Devices/Equipment/Supplies, Molecular Diagnostics, Personalized Medicine, Tumor Biology